Parkinson’s Research Pipeline: Medication for Cognition on the Horizon

Potential new medications for Parkinson’s cognitive decline With Parkinson’s disease (PD), cognitive issues are quite common. Yet, there are currently few medications available to help alleviate this troubling symptom. In the recent past, there were a scarcity of clinical trials testing potential medications for cognitive difficulties and PD. Currently, there is now a long list […]

Cognitive Rehabilitation for Parkinson’s Disease

Cognitive Changes are Common in Parkinson’s Cognitive difficulties are a common non-motor symptom in Parkinson’s disease (PD) and can affect many facets of everyday life. Executive function, or the ability to plan and organize multi-step activities can specifically be affected in PD. Visuo-spatial skills, which allow a person to navigate in three dimensions, estimating distances […]

Predicting the Progression of Parkinson’s Disease

What factors can predict Parkinson’s disease progression? People with Parkinson’s disease (PD) reasonably want to know how their disease will progress over time. Unfortunately, it is very hard to predict how any individual person’s PD will evolve, and neurologists often refrain from answering these questions. The Hoehn and Yahr Scale: Uses and Setbacks To quantify […]

Parkinson’s Disease & the Gut

Dr. Gilbert Answers Questions About Parkinson’s Disease and Gastrointestinal Issues On a recent episode of APDA’s Dr. Gilbert Hosts, I spoke with Dr. Ali Keshavarzian, a gastroenterologist with expertise on Parkinson’s disease and the gut. We covered a lot of ground and during the broadcast and answered questions from the audience. Further Reading: Learn about […]

Parkinson’s Disease Advice From Those Who Have “Been There”

Dr. Gilbert Hosts episode features advice on how to live with Parkinson’s On a recent episode of APDA’s Dr. Gilbert Hosts, I was joined by four exceptional people with Parkinson’s disease who shared their personal experiences with PD and answered your questions live. Collectively, they have been living with Parkinson’s for more than 60 years. […]

APDA-Funded Parkinson’s Research Successes: 2022 Update

APDA-funded Parkinson’s Research Successes: 2022 Update Since 1961, APDA has been a funding partner in many major scientific breakthroughs and has awarded nearly $55 million in Parkinson’s disease (PD) research grants to date. APDA funds individual research grants and fellowships to scientists performing innovative PD research.

The Future of Parkinson’s Disease Treatments – What’s New?

New Parkinson’s Disease Treatments in the Pipeline The pipeline for new Parkinson’s disease (PD) medications is very crowded, with multiple new medications in various stages of research development that are targeting neuroprotection, as well as motor and non-motor symptoms. In several past blogs we have reviewed many strategies currently being tested for PD, which you […]

What I wish I knew when I was first diagnosed with Parkinson’s Disease

Wisdom & Advice from People Living with Parkinson’s Disease  The voice of our Parkinson’s disease (PD) community is vibrant and full of excellent advice. And we know that hearing from those who have “been there” can be particularly helpful. For this article, we specifically consulted those who have more than a decade of experience with PD […]

Handwriting & Parkinson’s Disease

Writing Big: Parkinson’s Disease & Handwriting For today’s topic, we enlisted the expertise of Andie Hill, an Occupational Therapy student at the University of Mary in Bismarck, North Dakota. Recently, she has worked with APDA’s Northwest Chapter, helping people with PD manage various symptoms of PD and improve their quality of life, including issues with […]

Five Myths About Levodopa

Levodopa and Parkinson’s Disease When prescribed, levodopa is extremely effective in treating the motor symptoms of Parkinson’s disease (PD) and is embraced by many with PD. Many individuals see using Levodopa as a vital ingredient in maintaining movement and quality of life. It is the most prescribed medication for PD and has been the mainstay […]